FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neuropathology and psychiatry, and concerns method of purposeful selection of psychotropic agents, arresting negative symptoms in patients with depression, including assessment of patient's state, characterized by the fact that thrombocyte aggregation is determined in patient's plasma in vitro with agregometer after introduction to it of one of analyzed drugs intended for treatment and in case of recovering of adrenaline-aggregation of thrombocytes to norm relative to initial indicator, which is agregatogramm parameters, produced under adrenaline, this preparation is considered to be effective.
EFFECT: method provides possibility of purposeful selection of drug and dose, excluding stage of so-called "test treatment", significantly accelerates selection of optimal therapy, as well as allows to foresee potential side effects of drug therapy.
1 cl, 4 ex, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING PREPARATIONS FOR RELIEVING ATTACKS IN PATIENTS SUFFERING FROM PAROXYSM DISORDERS | 1999 |
|
RU2160900C1 |
METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
METHOD FOR TREATING BRONCHIAL ASTHMA COMBINED WITH EROSIVE-ULCEROUS KLESIONS OF GASTRODUODENAL AREA | 2004 |
|
RU2283097C2 |
METHOD OF TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA | 1999 |
|
RU2177326C2 |
METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
METHOD FOR DETECTING ANTIPLATELET DRUG RESISTANCE IN PATIENTS WITH PROGRESSING CEREBRAL ATHEROSCLEROSIS | 2012 |
|
RU2478965C1 |
METHOD OF TREATING SCHIZOPHRENIA | 2011 |
|
RU2484836C2 |
METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
METHOD FOR PREDICTING THERAPEUTICALLY RESISTANT DEPRESSIONS IN CASE OF ENDOGENOUS PSYCHIC DISEASES | 2005 |
|
RU2298190C1 |
Authors
Dates
2016-10-10—Published
2014-12-10—Filed